Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient’s own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation ...

Giving adrenaline to hospital patients whose heart has stopped is very effective, and can increase the chance of bringing ...

There are very few, if any, reasons to go to the mall anymore. If your local one hasn't become a decrepit ruin or closed ...

CHARLESTON, S.C. (WCSC) — An ongoing trial at the Medical University of South Carolina is looking for a breakthrough for patients dealing with heart failure. The condition is called heart failure with ...

PHOENIX — Imagine having a heart condition so severe you can’t walk to your mailbox — and then being told you’re too sick for treatment. That’s been the reality for thousands of people suffering from ...

With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor Therapeutics is one step closer to bringing a speedy new weapon to the race against ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and inflammation, potentially offering a powerful new way to protect the heart ...

Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc may also help prevent heart disease by lowering cholesterol and reducing ...

Panelists discuss how SGLT2 inhibitors evolved from diabetes medications to become foundational heart failure therapy with class I recommendations across the ejection fraction spectrum, providing ...

Panelists discuss how β-blockers remain foundational therapy for heart failure with reduced ejection fraction (using evidence-based agents like carvedilol, metoprolol succinate, or bisoprolol) with ...

This segment on The Three was paid for and sponsored by Abbot’s Heart Failure Division. Heart failure can completely derail someone’s life, but this new treatment might be making a huge difference.